Preclinical atherosclerosis and cardiovascular events: Do we have a consensus about the role of preclinical atherosclerosis in the prediction of cardiovascular events?

[1]  T. Villines,et al.  Predictors of Coronary Artery Calcium and Long‐Term Risks of Death, Myocardial Infarction, and Stroke in Young Adults , 2021, Journal of the American Heart Association.

[2]  I. V. Van Gelder,et al.  2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2021, European heart journal.

[3]  P. Gosse,et al.  SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium to Very High Risk , 2021, Hypertension.

[4]  G. Duan,et al.  Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches , 2020, Signal Transduction and Targeted Therapy.

[5]  Clemens Höbaus,et al.  Evaluation of sCD163 and sTWEAK in patients with stable peripheral arterial disease and association with disease severity as well as long-term mortality. , 2020, Atherosclerosis.

[6]  Andreas Fischer,et al.  The Endothelium: An Active Regulator of Lipid and Glucose Homeostasis. , 2020, Trends in cell biology.

[7]  J. De Sutter,et al.  Peripheral arterial disease and intermittent claudication in coronary heart disease patients. , 2020, International journal of cardiology.

[8]  L. Papazian,et al.  Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19 , 2020, The Journal of infectious diseases.

[9]  Ž. Reiner,et al.  Inflammatory Biomarkers for Cardiovascular Risk Stratification in Familial Hypercholesterolemia. , 2020, Reviews of physiology, biochemistry and pharmacology.

[10]  Baoguang Wang,et al.  Burn injuries related to E-cigarettes reported to poison control centers in the United States, 2010–2019 , 2020, Injury Epidemiology.

[11]  J. Hilden,et al.  Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease , 2020, Journal of the American Heart Association.

[12]  J. Mandrola,et al.  The Case Against Coronary Artery Calcium Scoring for Cardiovascular Disease Risk Assessment. , 2019, American family physician.

[13]  G. Hindricks,et al.  2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. , 2019, Atherosclerosis.

[14]  G. Gigli,et al.  ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease , 2019, Scientific Reports.

[15]  A. Khera,et al.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.

[16]  A. Ortiz,et al.  The role of endothelial glycocalyx in health and disease , 2019, Clinical kidney journal.

[17]  Thomas Kahan,et al.  [2018 ESC/ESH Guidelines for the management of arterial hypertension]. , 2019, Kardiologia polska.

[18]  J. Tao,et al.  Endothelial progenitor cells in cardiovascular diseases , 2018, Aging medicine (Milton (N.S.W)).

[19]  V. Fuster,et al.  Carotid plaque thickness and carotid plaque burden predict future cardiovascular events in asymptomatic adult Americans , 2018, European heart journal cardiovascular Imaging.

[20]  C. Patterson,et al.  Emerging Roles of Vascular Endothelium in Metabolic Homeostasis. , 2018, Circulation research.

[21]  M. Budoff,et al.  Coronary Calcium Score and Cardiovascular Risk. , 2018, Journal of the American College of Cardiology.

[22]  R. Kronmal,et al.  Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA) , 2018, European heart journal.

[23]  R. Koppensteiner,et al.  YKL-40 levels increase with declining ankle-brachial index and are associated with long-term cardiovascular mortality in peripheral arterial disease patients. , 2018, Atherosclerosis.

[24]  A. Sahebkar,et al.  Improvement of endothelial function by pitavastatin: a meta-analysis , 2018, Expert opinion on pharmacotherapy.

[25]  V. Fuster,et al.  Subclinical Atherosclerosis Burden by 3D Ultrasound in Mid-Life: The PESA Study. , 2017, Journal of the American College of Cardiology.

[26]  G. Nickenig,et al.  Extracellular Vesicles in Cardiovascular Disease: Potential Applications in Diagnosis, Prognosis, and Epidemiology , 2017, Circulation research.

[27]  C. Lewis,et al.  Association of Coronary Artery Calcium in Adults Aged 32 to 46 Years With Incident Coronary Heart Disease and Death , 2017, JAMA cardiology.

[28]  Wei Li,et al.  Clinical significance of sCD163 and its possible role in asthma , 2017, Molecular medicine reports.

[29]  Juan Wang,et al.  Novel biomarkers for cardiovascular risk prediction , 2017, Journal of geriatric cardiology : JGC.

[30]  A. Tislér,et al.  Measurement of Arterial Stiffness: A Novel Tool of Risk Stratification in Hypertension. , 2016, Advances in experimental medicine and biology.

[31]  A. Hoes,et al.  2016 European Guidelines on cardiovascular disease prevention in clinical practice. , 2016, Revista espanola de cardiologia.

[32]  T. Schuerholz,et al.  The Endothelial Glycocalyx: New Diagnostic and Therapeutic Approaches in Sepsis , 2016, BioMed research international.

[33]  R. Kronmal,et al.  Providing Evidence for Subclinical CVD in Risk Assessment. , 2016, Global heart.

[34]  R. Schnabel,et al.  Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease—results from the large AtheroGene study , 2016, European heart journal.

[35]  A. Sahebkar,et al.  Effects of statin therapy on augmentation index as a measure of arterial stiffness: A systematic review and meta-analysis. , 2016, International journal of cardiology.

[36]  A. Gnasso,et al.  Brachial Low-Flow-Mediated Constriction is Associated with Delayed Brachial Flow-Mediated Dilation. , 2016, Journal of atherosclerosis and thrombosis.

[37]  Song-Mei Liu,et al.  In-hospital free fatty acids levels predict the severity of myocardial ischemia of acute coronary syndrome , 2016, BMC Cardiovascular Disorders.

[38]  P. Poredos,et al.  Markers of preclinical atherosclerosis and their clinical relevance. , 2015, VASA. Zeitschrift fur Gefasskrankheiten.

[39]  V. Aboyans,et al.  The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. , 2015, Atherosclerosis.

[40]  V. Fuster,et al.  Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study , 2015, Circulation.

[41]  Yu Kataoka,et al.  Impact of statins on serial coronary calcification during atheroma progression and regression. , 2015, Journal of the American College of Cardiology.

[42]  C. Henschke,et al.  Low- vs. standard-dose coronary artery calcium scanning. , 2015, European heart journal cardiovascular Imaging.

[43]  Mario J. Garcia,et al.  Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study. , 2015, Journal of the American College of Cardiology.

[44]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[45]  E. Benjamin,et al.  Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. , 2014, Journal of the American College of Cardiology.

[46]  R. Draijer,et al.  Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. , 2013, International journal of cardiology.

[47]  M. Budoff,et al.  Coronary calcifications and plaque characteristics in patients with end-stage renal disease: a computed tomographic study , 2013, Coronary artery disease.

[48]  Jeroen J. Bax,et al.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2013, European heart journal.

[49]  H. Baxi,et al.  Journey in guidelines for lipid management: From adult treatment panel (ATP)-I to ATP-III and what to expect in ATP-IV , 2013, Indian journal of endocrinology and metabolism.

[50]  F. Sofi,et al.  Peripheral-Arterial Tonometry for Assessing Endothelial Function in Relation to Dietary Habits , 2013, Journal of Investigative Medicine.

[51]  R. Kronmal,et al.  Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis). , 2013, Journal of the American College of Cardiology.

[52]  M. Budoff,et al.  Association of lipoprotein subfractions and coronary artery calcium in patient at intermediate cardiovascular risk. , 2013, The American journal of cardiology.

[53]  E. Vicaut,et al.  Mannheim Carotid Intima-Media Thickness and Plaque Consensus (2004–2006–2011) , 2012, Cerebrovascular Diseases.

[54]  Giel Nijpels,et al.  Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. , 2012, JAMA.

[55]  Lu Gao,et al.  Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data , 2012, The Lancet.

[56]  G. Mancia,et al.  Risk stratification in cardiovascular disease primary prevention – scoring systems, novel markers, and imaging techniques , 2012, Fundamental & clinical pharmacology.

[57]  J. Filipovský,et al.  Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. , 2012, Journal of hypertension.

[58]  W. Ambrosius,et al.  Design of the Value of Imaging in Enhancing the Wellness of Your Heart (VIEW) trial and the impact of uncertainty on power , 2012, Clinical trials.

[59]  D. Berman,et al.  Prevalence and severity of coronary artery disease and adverse events among symptomatic patients with coronary artery calcification scores of zero undergoing coronary computed tomography angiography: results from the CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International , 2011, Journal of the American College of Cardiology.

[60]  J. J. Rivera,et al.  Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study , 2011, The Lancet.

[61]  S. Achenbach,et al.  Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology. , 2011, European heart journal.

[62]  M. Pencina,et al.  Carotid-wall intima-media thickness and cardiovascular events. , 2011, The New England journal of medicine.

[63]  L. Lind,et al.  Endothelial Function in Resistance and Conduit Arteries and 5-Year Risk of Cardiovascular Disease , 2011, Circulation.

[64]  L. Lerman,et al.  Effects of statins on coronary and peripheral endothelial function in humans: a systematic review and meta-analysis of randomized controlled trials , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[65]  Klaus Mann,et al.  Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. , 2010, Journal of the American College of Cardiology.

[66]  J. Michel,et al.  Peripheral Artery Disease Is Associated With a High CD163/TWEAK Plasma Ratio , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[67]  Eric Boerwinkle,et al.  Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. , 2010, Journal of the American College of Cardiology.

[68]  C. Vlachopoulos,et al.  Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. , 2010, Journal of the American College of Cardiology.

[69]  Michael J. Pencina,et al.  Arterial Stiffness and Cardiovascular Events: The Framingham Heart Study , 2010, Circulation.

[70]  T. Hansen,et al.  Risk stratification with the risk chart from the European Society of Hypertension compared with SCORE in the general population , 2009, Journal of hypertension.

[71]  Barbara P. Yawn,et al.  Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.

[72]  D. Green,et al.  Exercise Training as Vascular Medicine: Direct Impacts on the Vasculature in Humans , 2009, Exercise and sport sciences reviews.

[73]  A. Chagas,et al.  Asymmetric Dimethylarginine (ADMA) and Endothelial Dysfunction: Implications for Atherogenesis , 2009, Clinics.

[74]  A Hofman,et al.  Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. , 2008, JAMA.

[75]  R. Kronmal,et al.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups. , 2008, The New England journal of medicine.

[76]  F. Graziani,et al.  Myeloperoxidase: A New Biomarker of Inflammation in Ischemic Heart Disease and Acute Coronary Syndromes , 2008, Mediators of inflammation.

[77]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[78]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[79]  Steven Shea,et al.  Risk Factors for the Progression of Coronary Artery Calcification in Asymptomatic Subjects: Results From the Multi-Ethnic Study of Atherosclerosis (MESA) , 2007, Circulation.

[80]  T. Rabelink,et al.  Endothelial function and dysfunction: testing and clinical relevance. , 2007, Circulation.

[81]  D. Fryburg,et al.  Non‐traditional biomarkers of atherosclerosis in stable and unstable coronary artery disease, do they differ? , 2007, Acute cardiac care.

[82]  H. Struijker‐Boudier,et al.  Expert consensus document on arterial stiffness: methodological issues and clinical applications. , 2006, European heart journal.

[83]  M. Šabovič,et al.  Interleukin-6 Correlates with Endothelial Dysfunction in Young Post-Myocardial Infarction Patients , 2006, Cardiology.

[84]  U. Vischer,et al.  von Willebrand factor, endothelial dysfunction, and cardiovascular disease , 2006, Journal of thrombosis and haemostasis : JTH.

[85]  J. Constans,et al.  Circulating markers of endothelial function in cardiovascular disease. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[86]  Albert Hofman,et al.  Arterial Stiffness and Risk of Coronary Heart Disease and Stroke: The Rotterdam Study , 2006, Circulation.

[87]  Tine Willum Hansen,et al.  Prognostic Value of Aortic Pulse Wave Velocity as Index of Arterial Stiffness in the General Population , 2006, Circulation.

[88]  Richard A. Kronmal,et al.  Distribution of Coronary Artery Calcium by Race, Gender, and Age: Results from the Multi-Ethnic Study of Atherosclerosis (MESA) , 2005, Circulation.

[89]  A. Hofman,et al.  Coronary Calcification Improves Cardiovascular Risk Prediction in the Elderly , 2005, Circulation.

[90]  Sonia S Anand,et al.  Sensitivity and Specificity of the Ankle–Brachial Index to Predict Future Cardiovascular Outcomes: A Systematic Review , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[91]  E. Lakatta,et al.  Elevated Aortic Pulse Wave Velocity, a Marker of Arterial Stiffness, Predicts Cardiovascular Events in Well-Functioning Older Adults , 2005, Circulation.

[92]  Fred S Apple,et al.  Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. , 2005, Clinical chemistry.

[93]  Iftikhar J. Kullo,et al.  Progression of Subclinical Coronary Atherosclerosis: Does Obesity Make a Difference? , 2005, Circulation.

[94]  Françoise Dignat-George,et al.  Circulating endothelial cells , 2005, Thrombosis and Haemostasis.

[95]  Daniel S Berman,et al.  Prognostic value of coronary artery calcium screening in subjects with and without diabetes. , 2004, Journal of the American College of Cardiology.

[96]  Richard B Devereux,et al.  Relationship of High and Low Ankle Brachial Index to All-Cause and Cardiovascular Disease Mortality: The Strong Heart Study , 2004, Circulation.

[97]  C. Heeschen,et al.  Prognostic value of placental growth factor in patients with acute chest pain. , 2004, JAMA.

[98]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[99]  E. Topol,et al.  Prognostic value of myeloperoxidase in patients with chest pain. , 2003, The New England journal of medicine.

[100]  C. Heeschen,et al.  Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes , 2003, Circulation.

[101]  J. Winkles,et al.  TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor. , 2003, Cytokine & growth factor reviews.

[102]  S. Laurent,et al.  Aortic Stiffness Is an Independent Predictor of Fatal Stroke in Essential Hypertension , 2003, Stroke.

[103]  T. V. van Berkel,et al.  Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential , 2003, Pharmacological Reviews.

[104]  S. Anderson,et al.  Aortic Pulse-Wave Velocity and Its Relationship to Mortality in Diabetes and Glucose Intolerance: An Integrated Index of Vascular Function? , 2002, Circulation.

[105]  Jonathan G Goldin,et al.  Calcium begets calcium: progression of coronary artery calcification in asymptomatic subjects. , 2002, Radiology.

[106]  P. Libby,et al.  Inflammation and Atherosclerosis , 2002, Circulation.

[107]  S. Laurent,et al.  Aortic Stiffness Is an Independent Predictor of Primary Coronary Events in Hypertensive Patients: A Longitudinal Study , 2002, Hypertension.

[108]  M. Safar,et al.  Aortic Pulse Wave Velocity Predicts Cardiovascular Mortality in Subjects >70 Years of Age , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[109]  P. Ducimetiere,et al.  Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients , 2001, Hypertension.

[110]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[111]  P. Whincup,et al.  Femoral atherosclerosis in an older British population: prevalence and risk factors. , 2000, Atherosclerosis.

[112]  P. Ridker,et al.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.

[113]  C. Goonasekera.  Vascular Endothelial Cell Activation Associated with Increased Plasma Asymmetric Dimethyl Arginine in Children and Young Adults with Hypertension: A Basis for Atheroma? , 2000, Blood pressure.

[114]  J. Blacher,et al.  Impact of aortic stiffness on survival in end-stage renal disease. , 1999, Circulation.

[115]  Reinhold Förster,et al.  CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells , 1998, Nature.

[116]  M. Bell,et al.  Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. , 1995, Circulation.

[117]  A. Blann.  von Willebrand factor and atherosclerosis. , 1993, Journal of internal medicine.

[118]  M. Alderman,et al.  Role of Preclinical Cardiovascular Disease in the Evolution From Risk Factor Exposure to Development of Morbid Events , 1993, Circulation.

[119]  Gerardo Heiss,et al.  Carotid Artery Intimal‐Medial Thickness Distribution in General Populations As Evaluated by B‐Mode Ultrasound , 1993, Stroke.

[120]  J. Powell,et al.  On the accumulation of D-aspartate in elastin and other proteins of the ageing aorta. , 1992, Atherosclerosis.

[121]  C E Metz,et al.  Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. , 1982, Surgery.

[122]  J. Hobbs,et al.  Ankle systolic pressure measurements in arterial disease affecting the lower extremities , 1969, The British journal of surgery.

[123]  Rossella D'Oria,et al.  Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. , 2018, Vascular pharmacology.

[124]  V. Aboyans,et al.  Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases , in collaboration with the European Society for Vascular Surgery ( ESVS ) – Web Addenda , 2017 .

[125]  P. Poredos,et al.  Testing endothelial function and its clinical relevance. , 2013, Journal of atherosclerosis and thrombosis.

[126]  J. Vita.  Endothelial Function , 2011, Circulation.

[127]  R. Kronmal,et al.  Arterial age as a function of coronary artery calcium (from the Multi-Ethnic Study of Atherosclerosis [MESA]). , 2009, The American journal of cardiology.

[128]  L. Shaw,et al.  Prognostic value of number and site of calcified coronary lesions compared with the total score. , 2008, JACC. Cardiovascular imaging.

[129]  J. Kasprzak,et al.  Clinical aspects of assessment of endothelial function. , 2006, Pharmacological reports : PR.